XL177A   Click here for help

GtoPdb Ligand ID: 14636

Compound class: Synthetic organic
Comment: XL177A is reported as a covalent inhibitor of ubiquitin specific peptidase 7 (USP7) [1,3]. It forms a covalent bond with catalytic Cys223 within the USP7 active site.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 13
Hydrogen bond donors 3
Rotatable bonds 17
Topological polar surface area 150.25
Molecular weight 861.47
XLogP 1.64
No. Lipinski's rules broken 3

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN1CCN(CCC(=O)NC2=CC3=C(C=C2)C(=O)N(CC4(CCN(CC4)C(=O)[C@@H](CCCNC(=O)C5=CC=C6C(=C5)N=C7CCCCC7=C6Cl)CC8=CC=CC=C8)O)C=N3)CC1
Isomeric SMILES CN1CCN(CC1)CCC(=O)NC2=CC3=C(C=C2)C(=O)N(C=N3)CC4(CCN(CC4)C(=O)[C@@H](CCCNC(=O)C5=CC6=C(C=C5)C(=C7CCCCC7=N6)Cl)CC8=CC=CC=C8)O
InChI InChI=1S/C48H57ClN8O5/c1-54-24-26-55(27-25-54)21-17-43(58)52-36-14-16-39-41(30-36)51-32-57(47(39)61)31-48(62)18-22-56(23-19-48)46(60)35(28-33-8-3-2-4-9-33)10-7-20-50-45(59)34-13-15-38-42(29-34)53-40-12-6-5-11-37(40)44(38)49/h2-4,8-9,13-16,29-30,32,35,62H,5-7,10-12,17-28,31H2,1H3,(H,50,59)(H,52,58)/t35-/m0/s1
InChI Key UYJWYMWIVMCGQZ-DHUJRADRSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. El-Hamaky AA, El-Hamamsy MH, El-Moselhy TF, Sharafeldin N, Tawfik HO. (2025)
Therapeutic targeting of ubiquitin-specific protease 7 (USP7): Mechanistic insights, dysregulation, and advances in drug discovery.
Eur J Med Chem, 296: 117872. [PMID:40544656]
2. Maubach G, Hamann L, Stein M, Haak E, Naumann M. (2026)
Deubiquitinase inhibitors: from evolving concepts to preclinical evaluation.
Drug Discov Today,: 104751 [Epub ahead of print]. [PMID:42526627]
3. Schauer NJ, Liu X, Magin RS, Doherty LM, Chan WC, Ficarro SB, Hu W, Roberts RM, Iacob RE, Stolte B et al.. (2020)
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism.
Sci Rep, 10 (1): 5324. [PMID:32210275]